About Conference
Registration and abstract submission now open
EuroSciConis glad to welcome all the participants to24thEdition of International Conference on Biotechnologyschedule onApril 15-16, 2019inParis, France. The conference Theme:"Highlighting Latest Advancements and Applications of Biotechnology for Future Challenges"that focuses to share novel approaches related to biotechnology and exploring the challenges concerning excellence in research and advancements, we are pleased to invite allBiotechnologists, Professors,Researchers,scientists, Business Giants, CEOs, COOs, Directors, Vice Presidents, Co-directors, Managing Directors, Industry Safety Officers, Environmental & Plant Scientists, Post Doctorate Fellows, Vendors of Consumer Products/ Managers, Pharmaceutical Scientists, Students from the Biotechnology and its allied areas.
ThisInternational Biotechnology Conferencesproceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field ofBiotechnology.
EuroSciConis the longest running independent life science events company with a predominantly academic client base. Our multi professional approach creates a unique experience that cannot be found with a specialist society or commercially.
Euroscicon are corporate members of the following organisations:
Conference Topics:
Medical Biotechnology
Pharmaceutical Biotechnology
Biomedical Engineering and Bio-Engineering
Enzyme & Protein Engineering
Nanobiotechnology
Plant Biotechnology
Marine Biotechnology
Food & Feed Biotechnology
Animal Biotechnology
Cell Science & Cell Biology
Applied Biotechnology
Bio-Safety and Bioethics
Business Development
Microbial Biochemistry
Advancements In Biotechnology
Bioproducts and BioEnergy
Reproductive Biotechnology
Bioremediation and Biodegradation
Biotechnology
Nutritional Biotechnology
Environmental Biotechnology
Stem Cell Biotechnology
Industrial Biotechnology and Fermentation techniques
Genomics and Proteomics
Genetic Engineering and rDNA Technology
Biomaterials and Regenerative Medicine
Chemistry & System Biology
Biotechnology & Intellectual Property Rights
Cell Biology and Immunology
Bioinformatics and Biosensor
Biochemistry
Biophysics
Cell, Gene Therapy & DNA Repair
Industrial Biotechnology
Biotechnology And Bioprocess Engineering
Opportunities for Conference Attendees:
For Researchers & Faculty:
For Universities, Associations & Societies:
For Students & Research Scholars:
For Business Delegates:
For Companies:
Medical Biotechnology
Medical biotechnology refers to amedicinalor diagnostic product or a vaccine that consists of or has been produced in living organisms and may be manufactured via recombinant.Medical Biotechnology has a tremendous impact on meeting the needs of patients and their families as it not only encompasses medicines and diagnostics that are manufactured using abiotechnological process, but alsogeneandcell therapiesandtissue engineeredproducts. Today, the majority of innovativemedicines, whether manufactured usingbiotechnologyor via achemical synthesislike a traditional smallmolecule medicine, as well as many diagnostic products, are made available by applying modernbiotechnologyin their development and manufacturing
Pharmaceutical Biotechnology
Pharmaceutical biotechnologyis a comparatively new and growing field in which the principles ofbiotechnologyare applied to the designing and production ofdrugs.Pharmaceuticalcompanies manufacture and marketdrugs, livestockfeed supplements,vitamins, and a host of other products. Consistently,Pharmaceuticalcompanies are one of the most profitable industries in the U.S. with sales exceeding $320 billion per year.
Biomedical Engineering and Bio-Engineering
Biomedical engineering, orbioengineering, is the application of engineering principles to the fields of biology and health care.Bioengineerswork with doctors,therapistsandresearchersto develop systems, equipment and devices in order to solveclinical problems.
Biomedical engineershave developed a number of life-enhancing and life-saving technologies. These include:
Prosthetics, such asdenturesandartificial limbreplacements.
Surgical devices and systems, such as robotic and laser surgery.
Systems to monitor vital signs and blood chemistry.
Implanted devices, such asinsulin pumps, pacemakers and artificial organs.
Imaging methods, such as ultrasound, X-rays, particle beams and magnetic resonance.
Diagnostics, such as lab-on-a-chip and expert systems.
Therapeutic equipment and devices, such as kidney dialysis and transcutaneous electrical nerve stimulation (TENS).
Radiation therapy using particle beams and X-rays.
Physical therapy devices, such as exercise equipment and wearable tech.
Nanobiotechnology
Nano biotechnology is the multidisciplinary subject which combines engineering principles and molecular biology.Nano biotechnologyhas the potentiality to createbiological and biochemicalmaterials and devices at molecular and atomic levels. It presents new class of multifunctional systems and devices for biological analysis with better sensitivity and much specificity. Nano biotechnology subsumes the application of the tools and processes of nanotechnology to control biological systems. The Nano biotechnology includes new techniques such as3D imagininglive cells, real-time imaging, and single molecule imaging bio analytical microarrays and biosensors and microfluidic devices. This discipline helps to indicate the subsume of biological research with various fields of nanotechnology. Concepts that are enhanced through Nano biology comprises: Nano devices (such as biological machines), nanoparticles, and Nano scale phenomena that available within the discipline of nanotechnology. This technical approach to biology allows scientists to envisage and create systems that can be used for biological research.Biologicallyinspired nanotechnology uses biological systems as the encourisation for technologies not yet created. However, as with nanotechnology and biotechnology, bio nanotechnology does have many potential ethical issues associated with it.
Microbial Biochemistry
For thousands of years,microorganismshave been used to supply products such as bread, beer and wine. A second phase of traditional microbial biotechnology began during World War I and resulted in the development of the acetone-butanol andglycerol fermentations, followed by processes yielding, for example, citric acid, vitamins and antibiotics. In the early 1970s,traditional industrial microbiologywas merged withmolecular biologyto yield more than 40 biopharmaceutical products, such aserythropoietin, humangrowth hormoneandinterferons. Today, microbiology is a major participant in global industry, especially in the pharmaceutical, food and chemical industries.
Advancements In Biotechnology
Biotechnology as the name indicates that based on technology the progression of biology. Nowadays the whole world relies on technologies, into that where biology is our Base of life, & when scientists are using technology in biology it is doing wonders. Biotechnology can be used in several fields and sectors. For example in medical therapy, in war-fields (Bio--weapons), In agricultural biology, in reproductive biology, in cell biology, in genetic engineering. There is endless ways in which biotechnology is being used. It is a great combination which actually has the ability to change the impossible into possible.
Industrial Biotechnology and Fermentation techniques
Industrial or white biotechnology uses enzymes and micro-organisms to make bio based products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy. The application of industrial biotechnology has been proven to make significant contributions towards mitigating the impacts of climate change in these and other sectors. In addition to environmental benefits, biotechnology can improve industrys performance and product value and, as the technology develops and matures, white biotechnology will yield more and more viable solutions for our environment. These innovative solutions bring added benefits for both our climate and our economy.
Genetic Engineering and rDNA Technology
Genetic engineering is the manipulation of an organism's genome using biotechnology Principles. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species domains for the production of improved or novel organisms. Genetic engineering has applications in medicine, research, industry and agriculture and can be used on a wide range of plants, animals and microorganisms. Tissue engineering is the use of a integration of cells, engineering and materials principles, and suitable biochemical and physicochemical factors to improve or replace biological tissues.
Plant and Agriculture Biotechnology:
Agricultural biotechnology is the area of biotechnology involving applications to agriculture. Agricultural biotechnology has been practiced for a long time, as people have sought to improve agriculturally important organisms by selection and breeding. An example of traditional agricultural biotechnology is the development of disease-resistant wheat varieties by cross-breeding different wheat types until the desired disease resistance was present in a resulting new variety. Modern agricultural biotechnology improves crops in more targeted ways. The best known technique is genetic modification, but the term agricultural biotechnology (or green biotechnology) also covers such techniques as Marker Assisted Breeding, which increases the effectiveness of conventional breeding. Whatever the particular technology used, the crops may be destined for use for food, biomaterials or energy production. Genetic modification means that existing genes are modified or new genes included to give plant varieties desirable characteristics, such as resistance to certain pests or herbicides, or for vitamin fortification. Because only a few genes with known traits are transferred, GM methods are more targeted and faster than traditional breeding. Biotechnology has helped to increase crop productivity by introducing such qualities as disease resistance and increased drought tolerance to the crops. Plant biotechnology is the technique used to manipulate the plants for specific needs or requirement. In traditional process seed is the major source for germinating a new plant but the advance method is independent that combines multiple needs to get the required traits.
Bioproducts and BioEnergy
Bioenergy is renewable energy made available from materials derived from biological sources. Biomass is any organic material which has stored sunlight in the form of chemical energy. As a fuel it may include wood, wood waste, straw, manure, sugarcane etc. Bio-products are the application of plant-derived resources as an alternative to non-renewable matter. This sustainable approach considers the entire product life cycle from its agricultural origin to its overall renewability. Bio based innovation in the production and content of commonly used items assures consumers of improved environmental well-being without compromising product performance.
Reproductive Biotechnology
Reproductive Biotechnology encompasses all current and anticipated uses of technology in human and animal reproduction, including assisted reproductive technology, contraception and others. Efficient reproductive performance and monitoring are imperative for sustainability in any livestock production system, especially for milk, meat, draft, and replacement animals. In recent times, there has been increasing challenges for increasing productivity and disease with altering climate. These targets, thought to some extent, can be achieved by conventional reproduction techniques. Advent and use of modern reproductive technologies have opened many avenues to study, treat and manipulate the reproductive phenomenon both in vitro and in vivo to improve reproductive performance in various domestic species of livestock.
Bioremediation and Biodegradation
Bioremediation is a term used in biotechnology which is helping in cleaning the environment. Its a process in which the microorganisms or their enzymes are used to clean up environment which is contaminated. With the help of microorganisms certain compounds that are contaminating the environment are degraded.it is one of the solutions that are used to reduce the pollution. There are 2 types of bioremediation. In Biodegredation organic compounds are degraded or broken down with the help of microorganisms. The organic compound that is degraded is usually the animal and plant waste which is converted into certain elements that are returned to the environment and are used again usually by plants. The artificial compounds may also be bio degraded but these compounds must resemble the animal or plant waste or organic compounds. With the help of this biodegradation the elements or the nutrients are returned to the environment. It is a very important process. Usually the materials like certain plastics are manufactured focusing on the aspect that it should be biodegradable which can be degraded easily into simpler compounds. Biomass is an industry term for getting energy by burning wood, and other organic matter. Burning biomass releases carbon emissions, around a quarter higher than burning coal, but has been classed as a "renewable" energy source in the EU and UN legal frameworks, because plants can be regrown. Bioenergy is renewable energy made available from materials derived from biological sources. Biomass is any organic material which has stored sunlight in the form of chemical energy.
Environmental Biotechnology
Environmental biotechnology is biotechnology that is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. The International Society for Environmental Biotechnology defines environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments (land, air, water), and for environment-friendly processes.
Marine Biotechnology
See the original post:
International Biotechnology Conferences | Biotechnology ...
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance - November 16th, 2024
- Department of Biotechnology Launches Webinar Series on Biomanufacturing and Biofoundry Initiative - IBG NEWS - November 16th, 2024
- Multimodal scanning of genetic variants with base and prime editing - Nature.com - November 16th, 2024
- NEW INITIATIVE BY THE ITALIAN EMBASSY IN WASHINGTON ON BIOTECHNOLOGY WITH THE MILKEN INSTITUTE AND LEADING RESEARCHERS AND INDUSTRY EXPERTS -... - November 16th, 2024
- Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at... - November 16th, 2024
- Albany State offers new Master of Science in Integrated Biotechnology program - The Albany Herald - November 16th, 2024
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Benzinga - November 16th, 2024
- iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business - Simply Wall St - November 16th, 2024
- PDS Biotechnology Highlights Clinical Progress and Q3 Results - TipRanks - November 16th, 2024
- We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance - November 16th, 2024
- Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St - November 16th, 2024
- APHIS Announces Final Notice on Additional Exemptions for the Movement of Organisms Modified or Produced Through Genetic Engineering - USDA APHIS - November 16th, 2024
- Adaptimmune nears second approval for TCR-T therapy - European Biotechnology News - November 16th, 2024
- Lundbeck reports 18% revenue growth in third quarter - The Pharma Letter - November 16th, 2024
- BioNTech to boost oncology offering with buy of Biotheus - The Pharma Letter - November 16th, 2024
- Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - November 16th, 2024
- WPI Receives Federal Funding to Address Anticipated Demand for Biology and Biotechnology Professionals and Educators - WPI News - November 3rd, 2024
- Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research - College of Computer, Mathematical, and Natural Sciences - November 3rd, 2024
- PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat - November 3rd, 2024
- COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved - Renewable Matter - November 3rd, 2024
- Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire - November 3rd, 2024
- Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter - November 3rd, 2024
- Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter - November 3rd, 2024
- AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter - November 3rd, 2024
- CEO and Chairman of the Executive Board - European Biotechnology News - November 3rd, 2024
- The transformative potential of biotechnology and AI in healthcare - The Armchair Trader - November 3rd, 2024
- U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
- Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
- Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
- Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
- Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
- Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
- Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
- Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022